See more : Shenwan Hongyuan Group Co., Ltd. (000166.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Telescope Innovations Corp. (TELIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Telescope Innovations Corp., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Oragin Foods Inc. (OG.V) Income Statement Analysis – Financial Results
- Atlas Copco AB (ACO1.F) Income Statement Analysis – Financial Results
- HUB Cyber Security Ltd. (HUBCZ) Income Statement Analysis – Financial Results
- Cairo Communication S.p.A. (CAI.MI) Income Statement Analysis – Financial Results
- LeanLife Health Inc. (LNLHF) Income Statement Analysis – Financial Results
Telescope Innovations Corp. (TELIF)
About Telescope Innovations Corp.
Telescope Innovations Corp., a chemical technology company, engages in developing synthetic processes to access pharmaceuticals for the treatment of mental health. The company is headquartered in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 2.82M | 595.40K | 0.00 | 0.00 |
| Cost of Revenue | 3.50K | 930.15K | 15.65K | 0.00 |
| Gross Profit | 2.82M | -334.75K | -15.65K | 0.00 |
| Gross Profit Ratio | 99.88% | -56.22% | 0.00% | 0.00% |
| Research & Development | 0.00 | 59.56K | 129.83K | 221.25K |
| General & Administrative | 2.25M | 5.60M | 3.72M | 140.06K |
| Selling & Marketing | 82.85K | 13.32K | 4.90K | 20.16K |
| SG&A | 2.33M | 5.62M | 3.72M | 31.73K |
| Other Expenses | 0.00 | -930.15K | -15.65K | 0.00 |
| Operating Expenses | 3.54M | 6.35M | 4.02M | 252.98K |
| Cost & Expenses | 3.55M | 6.35M | 4.02M | 252.98K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 2.44K |
| Depreciation & Amortization | 303.60K | 276.34K | 236.56K | 206.30K |
| EBITDA | -421.78K | -5.49M | -4.02M | -252.98K |
| EBITDA Ratio | -14.94% | -922.15% | 0.00% | 0.00% |
| Operating Income | -725.38K | -5.77M | -4.02M | -252.98K |
| Operating Income Ratio | -25.69% | -968.56% | 0.00% | 0.00% |
| Total Other Income/Expenses | 3.64K | 9.87K | -1.71K | 2.00 |
| Income Before Tax | -718.09K | -5.75M | -4.03M | -252.98K |
| Income Before Tax Ratio | -25.43% | -965.24% | 0.00% | 0.00% |
| Income Tax Expense | -3.64K | -9.87K | -885.06K | -233.52K |
| Net Income | -718.09K | -5.75M | -4.03M | -252.98K |
| Net Income Ratio | -25.43% | -965.24% | 0.00% | 0.00% |
| EPS | -0.01 | -0.12 | -0.08 | -0.01 |
| EPS Diluted | -0.01 | -0.12 | -0.08 | -0.01 |
| Weighted Avg Shares Out | 52.72M | 48.42M | 47.79M | 47.79M |
| Weighted Avg Shares Out (Dil) | 52.72M | 48.42M | 47.79M | 47.79M |
Telescope Innovations Develops Novel Battery Recycling Technology
A new approach isolates lithium and valuable transition metals from battery recycling feeds Vancouver, British Columbia--(Newsfile Corp. - April 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is leading a developer of advanced technologies and services...
Telescope Innovations and Shimadzu Scientific Instruments Initiate Technology Partnership
Telescope pairs its DirectInject-LC(TM) technology with Shimadzu's chemical analysis instrumentation Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical...
Telescope Innovations Strengthens Senior Management: Henry Dubina Appointed as CEO, Dr. Jason Hein as CTO, John Kirincic as CFO, Deborah Cotter as Corporate Secretary
Vancouver, British Columbia--(Newsfile Corp. - February 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to welcome Henry Dubina as Chairman...
Mettler Toledo and Telescope Innovations Agree to Globally Distribute Telescope's Flagship Product, DirectInject-LC(TM)
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces it has signed a Distribution Agreement with...
Telescope Innovations Presents Results of First Fiscal Quarter 2024
The Company exceeded its quarterly revenue and profit records in Q1, 2024 Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for...
Telescope Innovations Files Game-Changing Provisional Patent to Purify Battery Materials
A novel refinement process generates battery-quality lithium carbonate in a single step Vancouver, British Columbia--(Newsfile Corp. - January 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company") is a developer of advanced technologies and services...
Telescope Innovations Reports Strong Growth in Fiscal Year 2023
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal...
Telescope Innovations Develops New IP for the Production of Battery Materials
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces it has filed a provisional...
Telescope Innovations and Mott Corporation Initiate Technology Partnership
The chem tech and precision filtration companies plan to develop a novel robotic sampling probe Vancouver, British Columbia--(Newsfile Corp. - October 30, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies...
Telescope Innovations Product Deployed by 13 Pharma Giants in First Year
Vancouver, British Columbia--(Newsfile Corp. - October 4, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) ("Telescope" or the "Company"), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, is excited to announce that its flagship...
Source: https://incomestatements.info
Category: Stock Reports